Annual tour showcases latest research from the Institute for Infection and Immunity

From developing new approaches to vaccination against tuberculosis, to learning about how tobacco plants can be used for growing drugs in the developing world, researchers in the Infection and Immunity Research Institute explained what they’ve been up to.

 Professor Julian Ma

Cannabinoids used in sequence with chemotherapy are a more effective treatment for cancer

New research has confirmed that cannabinoids - the active chemicals in cannabis - are effective in killing leukaemia cells, particularly when used in combination with chemotherapy treatments.

New Strategic Plan sets direction for the next five years

The St George’s, University of London Strategic Plan 2017-22 was launched on 24 May 2017. The strategy captures what is important to our community at St George’s and sets out how we will sustain our excellence and impact for the next five years.

 DSC7343 Cropped

Drug market blamed for problems treating sick children

Antibiotics used to treat a variety of common bacterial infections are becoming more difficult to access, mostly because the drugs are less profitable for manufacturers to produce and market, say experts.

Institute director gets prestigious Fellowship

Professor Dorothy Bennett, Director of our Molecular and Clinical Sciences Research Institute, has been elected a Fellow of the Academy of Medical Sciences.

Prof. Dot Bennett